T
475960
vs
K
KOSPI 200
Over the past 12 months, Tomocube Inc has underperformed KOSPI 200, delivering a return of -17% compared to KOSPI 200's +146% growth.
Stocks Performance
475960 vs KOSPI 200
Performance Gap
475960 vs KOSPI 200
Performance By Year
475960 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Tomocube Inc
Glance View
Tomocube makes optical imaging systems for scientists and drug developers. Its main products are holotomography microscopes, which let users look inside living cells in 3D without staining or damaging the sample. The company also sells software and service contracts that go with the instruments. Its customers are mainly research labs, universities, pharmaceutical companies, and biotech firms. These buyers use Tomocube’s systems for cell biology, cancer research, drug screening, and other lab work where seeing how cells change in real time matters. Tomocube earns money when it sells the microscopes, related software, upgrades, and ongoing support. What makes Tomocube different is that it sits at the high-end imaging step of the life-science tools market. Instead of making broad lab equipment, it focuses on a specialized microscope platform that gives researchers label-free, live-cell views that are hard to get with standard optical tools. That makes it a niche supplier to customers who need very detailed cell analysis rather than simple routine imaging.
